Arianna Almirall Sanchez, MD, MSc
General Practitioner, Bio-statistician
To diminish the impact of dementia and cognitive impairment, we must work together to develop new tools to detect and diagnose these diseases sooner.
Arianna is a biostatistician and Head of Research Projects at the National Institute of Oncology and Radiobiology in Cuba. She is researching the relationship between cognitive reserve and cognitive decline by analyzing population data from high, middle and low income countries to identify mid-life risk factors for dementia.
Words of Strength
Creating networks, being passionate
To reduce the scale and impact of dementia we need to improve the diagnosis of neurocognitive disorders from primary care and engage general practitioners and other primary care physicians into this process.
There are current interventions taking place in Cuba that include the use of technology-based cognitive assessment and the feasibility of its extension countrywide. These interventions would help the early diagnosis and follow up of patients with cognitive impairment in the country.
The Cuban population is one of the oldest in Latin America with a prevalence rate of dementia syndrome between 6.4-10.2%. Consequently, early and accurate diagnosis of neurocognitive disorders from primary health care is crucial.
Arianna received her medical school training and both specializations (Bio-statistics and General Practitioner) from the Universidad de la Habana, Cuba. She received her master’s degree in Clinical Trials from the Cuban National School of Public Health. After completing her master degree, she has joined the Clinical Trials Department at Cuban Institute of Oncology and Radiology as bio-statistician and to the Cuban Neurology Institute as a research assistant